The neuroregenerative properties of FK506, an FKBP-12 ligand that inhibits
calcineurin, and V-10,367, an FKBP-12 ligand that does not inhibit calcineu
rin, were evaluated in crush and transection models. Rats were randomly ass
igned to one of seven groups, including untreated controls and FK506- or V-
10,367-treated experimental groups. Following crush or transection nerve in
jury, animals were assessed with walking tracks, and histomorphometry FK506
-treated animals demonstrated significant functional recovery 11 days follo
wing crush and 18 days following transection injury. In untreated and V-10,
367 treated animals, nerves recovered 13 days following crush injury, but d
id not improve significantly prior to sacrifice at 28 days in animals susta
ining a transection injury. No statistically significant differences in his
tomorphometric parameters were identified between any of the groups, The st
udy confirms that FK506 accelerates recovery from tibial nerve injury.